Cargando…
Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage (DASH): protocol for a phase II double-blind randomised controlled feasibility trial
INTRODUCTION: Intracerebral haemorrhage (ICH) can be devastating and is a common cause of death and disability worldwide. Pre-ICH antiplatelet drug use is associated with a 27% relative increase in 1 month case fatality compared with patients not using antithrombotic drugs. We aim to assess the feas...
Autores principales: | Desborough, Michael J R, Al-Shahi Salman, Rustam, Stanworth, Simon J, Havard, Diane, Brennan, Paul M, Dineen, Robert A, Coats, Timothy J, Hepburn, Trish, Bath, Philip M, Sprigg, Nikola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656949/ https://www.ncbi.nlm.nih.gov/pubmed/33172941 http://dx.doi.org/10.1136/bmjopen-2020-037555 |
Ejemplares similares
-
Desmopressin for patients with spontaneous intracerebral haemorrhage taking antiplatelet drugs (DASH): a UK-based, phase 2, randomised, placebo-controlled, multicentre feasibility trial
por: Desborough, Michael J R, et al.
Publicado: (2023) -
Does tranexamic acid lead to changes in MRI measures of brain tissue health in patients with spontaneous intracerebral haemorrhage? Protocol for a MRI substudy nested within the double-blind randomised controlled TICH-2 trial
por: Dineen, Rob A, et al.
Publicado: (2018) -
Outcomes in Antiplatelet‐Associated Intracerebral Hemorrhage in the TICH‐2 Randomized Controlled Trial
por: Law, Zhe Kang, et al.
Publicado: (2021) -
Statistical analysis plan for the ‘Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke’ (TARDIS) trial
por: Bath, Philip M W, et al.
Publicado: (2015) -
Desmopressin Acetate in Intracranial Haemorrhage
por: Kapapa, Thomas, et al.
Publicado: (2014)